DIGITOME
LIVE

Serial Number

88118686

Owner

Medable, Inc.

Attorney

Omar M. Wadhwa

First Use Date

Oct 11, 2017

Filing Date

Sep 15, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DIGITOME Trademark

Serial Number: 88118686 • Registration: 6010838

DIGITOME is a trademark filed by Medable, Inc. on September 15, 2018. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Medable, Inc. (58 trademarks)

555 Bryant St. #561
Palo Alto, CA 94301

Entity Type: 03

Trademark Details

Filing Date

September 15, 2018

Registration Date

March 17, 2020

First Use Anywhere

October 11, 2017

First Use in Commerce

October 11, 2017

Published for Opposition

December 31, 2019

Goods & Services

Health care services, namely, providing a database in the field of disease detection and management information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of disease therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes

Software as a service (SAAS) services, namely, hosting software for use by others for use for disease progression prediction; Software as a service (SAAS) services, namely, hosting software for use by others for use for medical status assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use for overall health assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use to determine effective therapies and medications; Software as a service (SAAS) services, namely, hosting software for use by others for use to make medical decisions; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of human health and disease data; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of genetic data; Application service provider (ASP) featuring software for use to derive insights and or understanding about human health and disease.; Application service provider (ASP) featuring software for use for predictive analytics; Application service provider (ASP) featuring software for use for disease progression prediction; Application service provider (ASP) featuring software for use for medical status assessment; Application service provider (ASP) featuring software for use for overall health assessment; Application service provider (ASP) featuring software for use to determine effective therapies and medications; Application service provider (ASP) featuring software for use to make medical decisions; Application service provider (ASP) featuring software for use to assist in overall medical and therapeutic decision making; Conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Medical and scientific research, namely, conducting clinical trials for others; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of human health and disease data; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of genetic data; Platform as a service (PAAS) featuring computer software platforms for to derive insights and or understanding about human health and disease.; Platform as a service (PAAS) featuring computer software platforms for for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for for medical status assessment; Platform as a service (PAAS) featuring computer software platforms for for overall health assessment; Platform as a service (PAAS) featuring computer software platforms for to determine effective therapies and medications; Platform as a service (PAAS) featuring computer software platforms for to make medical decisions; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 17, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 4, 2019 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 26, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 26, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 26, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 26, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 26, 2019 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 6, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 6, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 6, 2019 CNRT
NOTICE OF REVIVAL - E-MAILED
Sep 30, 2019 NREV
PETITION TO REVIVE-GRANTED
Sep 30, 2019 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 30, 2019 PROA
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 30, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 30, 2019 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 1, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 1, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 1, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2018 NWOS
NEW APPLICATION ENTERED
Sep 19, 2018 NWAP